Management of Crohn's disease
- PMID: 26553907
- PMCID: PMC4853609
- DOI: 10.1136/archdischild-2014-307217
Management of Crohn's disease
Abstract
Crohn's disease (CD) is rapidly increasing in children so an up to date knowledge of diagnosis, investigation and management is essential. Exclusive enteral nutrition is the first line treatment for active disease. The vast majority of children will need immunosuppressant treatment and around 20% will need treatment with biologics. Recent guidelines have helped make best use of available therapies.
Keywords: Gastroenterology; Therapeutics.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures


Similar articles
-
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23. Gastroenterology. 2024. PMID: 38276922
-
An update on dietary therapies in paediatric Crohn's disease.Curr Opin Clin Nutr Metab Care. 2024 May 1;27(3):304-312. doi: 10.1097/MCO.0000000000001024. Epub 2024 Feb 28. Curr Opin Clin Nutr Metab Care. 2024. PMID: 38456807 Review.
-
Exclusive enteral nutrition practices in the management of Crohn's disease: A cross sectional survey of specialist paediatric dietitians.Clin Nutr ESPEN. 2022 Jun;49:252-255. doi: 10.1016/j.clnesp.2022.04.006. Epub 2022 Apr 12. Clin Nutr ESPEN. 2022. PMID: 35623822
-
Exclusive enteral nutrition in children with Crohn's disease.World J Gastroenterol. 2015 Jun 14;21(22):6809-16. doi: 10.3748/wjg.v21.i22.6809. World J Gastroenterol. 2015. PMID: 26078556 Free PMC article. Review.
-
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.Inflamm Res. 2024 Feb;73(2):199-209. doi: 10.1007/s00011-023-01828-7. Epub 2024 Jan 2. Inflamm Res. 2024. PMID: 38168701 Free PMC article.
Cited by
-
Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results.Hum Cell. 2021 Sep;34(5):1289-1300. doi: 10.1007/s13577-021-00560-w. Epub 2021 May 31. Hum Cell. 2021. PMID: 34057700 Free PMC article. Review.
-
Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.PLoS One. 2021 Mar 25;16(3):e0248482. doi: 10.1371/journal.pone.0248482. eCollection 2021. PLoS One. 2021. PMID: 33764993 Free PMC article.
-
Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort.World J Gastroenterol. 2016 Dec 28;22(48):10653-10662. doi: 10.3748/wjg.v22.i48.10653. World J Gastroenterol. 2016. PMID: 28082818 Free PMC article.
-
Treating children with inflammatory bowel disease: Current and new perspectives.World J Gastroenterol. 2017 Aug 14;23(30):5469-5485. doi: 10.3748/wjg.v23.i30.5469. World J Gastroenterol. 2017. PMID: 28852307 Free PMC article. Review.
-
Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?Ann Gastroenterol. 2019 Jul-Aug;32(4):387-391. doi: 10.20524/aog.2019.0381. Epub 2019 May 10. Ann Gastroenterol. 2019. PMID: 31263361 Free PMC article.
References
-
- Henderson P, Rogers P, Gillett PM, et al. . The epidemiology and natural history of paediatric inflammatory bowel disease in a UK region: a prospective 14-year study. Arch Dis Child 2012;97(Suppl 1):A53–A54.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical